Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 328Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

ORIGINAL ARTICLE

Adverse drug reactions to antiretroviral therapy: Results from spontaneous reporting system in Nigeria

Agu Kenneth A, Oparah Azuka C

Year : 2013| Volume: 4| Issue : 2 | Page no: 117-124

   This article has been cited by
 
1 Short-Term Adverse Drug Reactions to Antiretroviral Therapy in Children with HIV: A Cohort Study
Sandip Ray, Anju Seth, Sarita Singh, Garima Sharma, Neha Gaur, Yukti Shah, Praveen Kumar, Jagdish Chandra
Indian Journal of Pediatrics. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Adverse drug reaction patterns of anti-retroviral drugs: A study in a tertiary care teaching Institute of north east India
CHRISTINA ZOSANGPUII, SWAGATA DATTA, NGANGOM GUNINDRO, DN MEENA, SURJIT SINGH NAMEIRAKPAM
Asian Journal of Pharmaceutical and Clinical Research. 2022; : 38
[Pubmed]  [Google Scholar] [DOI]
3 Treatment outcome of different antiretroviral drug regimens in HIV-positive pregnant women
Nidhi Chauhan,Mira Desai,Samidh Shah,Asha Shah,Rajendra Gadhavi
Perspectives in Clinical Research. 2021; 12(1): 40
[Pubmed]  [Google Scholar] [DOI]
4 Annual Costs Incurred in Managing Adverse Drug Reactions Attributable to Fixed-Dose Combination Highly Active Antiretroviral Therapy in an Outpatient Antiretroviral Clinic in Gauteng: A Budget Impact Analysis
Grace Chikeya,Frasia Oosthuizen,Varsha Bangalee
Value in Health Regional Issues. 2021; 25: 142
[Pubmed]  [Google Scholar] [DOI]
5 Neuropsychiatric Effects of Antiviral Drugs
Nicholas Zareifopoulos,Maria Lagadinou,Anastasia Karela,Ourania Kyriakopoulou,Dimitrios Velissaris
Cureus. 2020;
[Pubmed]  [Google Scholar] [DOI]
6 Nature and prevalence of adverse drug reaction of antiretroviral medications in Halibet National Referral Hospital: a retrospective study
Lidya Hagos,Siyoma Fessehaye,Indermeet Singh Anand
BMC Pharmacology and Toxicology. 2019; 20(1)
[Pubmed]  [Google Scholar] [DOI]
7 Pharmacovigilance in perspective: drug withdrawals, data mining and policy implications
Muaed Alomar,Subish Palaian,Moawia M. Al-tabakha
F1000Research. 2019; 8: 2109
[Pubmed]  [Google Scholar] [DOI]
8 A Retrospective Review of Serious Adverse Drug Reaction Reports in the Nigerian VigiFlow Database from September 2004 to December 2016
Comfort Kunak Ogar,Abiodun Abiola,Daniel Yuah,Ali Ibrahim,Ibrahim Adekunle Oreagba,Emmanuel C. Amadi,Mojisola Christianah Adeyeye,Kazeem Adeola Oshikoya
Pharmaceutical Medicine. 2019;
[Pubmed]  [Google Scholar] [DOI]
9 The life-threatening eruption in HIV and immunosuppression
Marcia Ramos-e-Silva,Pedro Secchin,Beatriz Trope
Clinics in Dermatology. 2019;
[Pubmed]  [Google Scholar] [DOI]
10 Named entity recognition from Chinese adverse drug event reports with lexical feature based BiLSTM-CRF and tri-training
Yao Chen,Changjiang Zhou,Tianxin Li,Hong Wu,Xia Zhao,Kai Ye,Jun Liao
Journal of Biomedical Informatics. 2019; 96: 103252
[Pubmed]  [Google Scholar] [DOI]
11 The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database
Genaro Castillon,Francesco Salvo,Yola Moride
Drug Safety. 2018;
[Pubmed]  [Google Scholar] [DOI]
12 Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria
Olufunsho Awodele,Rebecca Aliu,Ibrahim Ali,Yetunde Oni,Christianah Mojisola Adeyeye
Pharmacology Research & Perspectives. 2018; 6(5): e00427
[Pubmed]  [Google Scholar] [DOI]
13 Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV/AIDS, Tuberculosis and Malaria: A prospective cohort study
Yohanna Kambai Avong,Bolajoko Jatau,Ritmwa Gurumnaan,Nanfwang Danat,James Okuma,Istifanus Usman,Dennis Mordi,Blessing Ukpabi,Gbenga Ayodele Kayode,Saswata Dutt,Osman El-Tayeb,Bamgboye Afolabi,Isah Ambrose,Oche Agbaji,Adeline Osakwe,Ali Ibrahim,Comfort Ogar,Helga Nosiri,Eunice B. Avong,Victor Adekanmbi,Olalekan Uthman,Alash’le Abimiku,Yetunde O. Oni,Charles Olalekan Mensah,Patrick Dakum,Kamau Edward Mberu,Olumide A. T. Ogundahunsi,Albert Figueras
PLOS ONE. 2018; 13(8): e0200810
[Pubmed]  [Google Scholar] [DOI]
14 Prevalence and Clinical Profile of Drug Eruptions among Antiretroviral Therapy-Exposed HIV Infected People in Yaoundé, Cameroon
Emmanuel Armand Kouotou,Jobert Richie Nansseu,Vanessa Nancy Ngono,Sandra A. Tatah,Anne Cecile Zoung-Kanyi Bissek,Elie Claude Ndjitoyap Ndam
Dermatology Research and Practice. 2017; 2017: 1
[Pubmed]  [Google Scholar] [DOI]
15 Sentinel site active surveillance of safety of first-line antiretroviral medicines in Namibia
Marita Mann,Assegid Mengistu,Johannes Gaeseb,Evans Sagwa,Greatjoy Mazibuko,Jared M. Baeten,Joseph B. Babigumira,Louis P. Garrison,Andy Stergachis
Pharmacoepidemiology and Drug Safety. 2016;
[Pubmed]  [Google Scholar] [DOI]
16 Pharmacovigilance in Nigeria: An Overview
Abimbola Olowofela,Annie Fourrier-Réglat,Ambrose O. Isah
Pharmaceutical Medicine. 2016;
[Pubmed]  [Google Scholar] [DOI]
17 Patterns of adverse drug reaction signals in NAFDAC Pharmacovigilance activities from September to November, 2014
Olufunsho Awodele,Ali Ibrahim,Paul Orhii
International Journal of Risk & Safety in Medicine. 2016; 28(1): 13
[Pubmed]  [Google Scholar] [DOI]
18 Influence of Adverse Drug Reactions on Treatment Success: Prospective Cohort Analysis of HIV-Infected Individuals Initiating First-Line Antiretroviral Therapy in India
Anita Shet,Jimmy Antony,Karthika Arumugam,Sunil Kumar Dodderi,Rashmi Rodrigues,Ayesha DeCosta,Wenzhe Ho
PLoS ONE. 2014; 9(3): e91028
[Pubmed]  [Google Scholar] [DOI]

 

Read this article